Lim, Joseph K.
Yale University
10 papers on CoChatORCID 0000-0003-1126-8128
Most cited papers
- Verified
Longitudinal analyses reveal immunological misfiring in severe COVID-19
Lucas, C., Wong, P., Klein, J., Castro, T. B. R., Silva, J., Sundaram, M., Ellingson, M. K., Mao, T., Oh, J. E., Israelow, B., et al. (2020) · Nature
COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research
Cited by 2,074
- Verified
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: Interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
Younossi, Z. M., Ratziu, V., Loomba, R., Rinella, M., Anstee, Q. M., Goodman, Z., Bedossa, P., Geier, A., Beckebaum, S., Newsome, P. N., et al. (2019) · The Lancet
Liver Disease Diagnosis and TreatmentLiver Diseases and Immunity
Cited by 1,277
- Verified
ACG clinical guideline: evaluation of abnormal liver chemistries
Kwo, P. Y., Cohen, S. M., & Lim, J. K. (2017) · American Journal of Gastroenterology
Liver Disease Diagnosis and TreatmentLiver Diseases and Immunity
Cited by 1,222
- Verified
American gastroenterological association institute guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts
Vege, S. S., Ziring, B., Jain, R., Moayyedi, P., Adams, M. A., Dorn, S. D., Dudley-Brown, S. L., Flamm, S. L., Gellad, Z. F., Gruss, C. B., et al. (2015) · Gastroenterology
Pancreatic and Hepatic Oncology ResearchPancreatitis Pathology and Treatment
Cited by 1,138
- Verified
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials
Harrison, S. A., Wong, V. W.-S., Okanoue, T., Bzowej, N., Vuppalanchi, R., Younes, Z., Kohli, A., Sarin, S., Caldwell, S. H., Alkhouri, N., et al. (2020) · Journal of Hepatology
Liver Disease Diagnosis and TreatmentLiver physiology and pathology
Cited by 497
- Verified
AGA Institute Rapid Review of the Gastrointestinal and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19
Sultan, S., Altayar, O., Siddique, S. M., Davitkov, P., Feuerstein, J. D., Lim, J. K., Falck-Ytter, Y., & El-Serag, H. B. (2020) · Gastroenterology
COVID-19 Clinical Research StudiesLong-Term Effects of COVID-19
Cited by 437
- Verified
AGA Clinical Practice Update: Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Lean Individuals: Expert Review
Long, M. T., Noureddin, M., & Lim, J. K. (2022) · Gastroenterology
Liver Disease Diagnosis and TreatmentLiver Diseases and Immunity
Cited by 299
- Verified
AGA clinical practice update on the role of noninvasive biomarkers in the evaluation and management of nonalcoholic fatty liver disease: expert review
Wattacheril, J. J., Abdelmalek, M. F., Lim, J. K., & Sanyal, A. J. (2023) · Gastroenterology
Liver Disease Diagnosis and TreatmentLiver Diseases and Immunity
Cited by 236
- Verified
. FIB-4 index is associated with hepatocellular carcinoma risk in HIV-infected patients.
Park, L. S., Tate, J. P., Justice, A. C., Lo Re, V., Lim, J. K., Bräu, N., Brown, S. T., Butt, A. A., Gibert, C., Goetz, M. B., et al. (2011) · Cancer Epidemiology, Biomarkers & Prevention
Liver Disease Diagnosis and TreatmentHepatocellular Carcinoma Treatment and Prognosis
Cited by 38
- Verified
Exercise does not independently improve histological outcomes in biopsy-proven non-alcoholic fatty liver disease: a systematic review and meta-analysis
Chen, G., Banini, B. A., Do, A., Gunderson, C., Zaman, S., & Lim, J. K. (2023) · Genes
Liver Disease Diagnosis and TreatmentPhysical Activity and Health
Cited by 15
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free